Researchers investigated the function of the oncogenic BAP1/ASXL3/BRD4 epigenetic axis in small cell lung cancer by developing a next-generation BAP1 inhibitor.
[Oncogene]
Sorry, but the selected Zotpress account can't be found.
Home Newsletters Pulmonary Cell News Therapeutic Targeting of BAP1/ASXL3 Sub-complex in ASCL1-Dependent Small Cell Lung Cancer
